Effectiveness of Gold Fixed Retainers Compared to Conventional Stainless Steel Retainers

NCT ID: NCT07280455

Last Updated: 2025-12-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-11-01

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized clinical trial will compare the effectiveness of a gold-plated multistranded mandibular fixed retainer versus a conventional multistranded stainless-steel fixed retainer in maintaining lower anterior tooth alignment after completion of orthodontic treatment. Eligible participants (post-orthodontic patients requiring mandibular fixed retention) will be allocated in a 1:1 ratio to receive either a gold-plated 0.0195-inch multistranded retainer or an identical-gauge 0.0195-inch stainless-steel multistranded retainer. Participants will be followed for 6 months.

The primary outcome is post-treatment stability of mandibular anterior alignment, assessed by changes in Little's Irregularity Index over time, along with retainer failure outcomes (e.g., time to first failure and tooth-level failure events). Secondary outcomes include periodontal health indices and related clinical measures collected at baseline and follow-up visits.

For the microbiological assessment, plaque/biofilm will be collected from the retainer using sterile swabs at 1 month, 3 months, and 6 months to evaluate bacterial levels associated with each retainer material.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Orthodontic Retention Appliance Orthodontic Relapse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Masking is used for participants, outcome assessors, and the data analyst. The treating orthodontist (care provider) who places the fixed retainer cannot be blinded due to visible differences between the retainer wire types. Participants are not informed of group assignment. Outcome assessments are performed on coded study records/models by a blinded examiner, and the dataset is coded prior to statistical analysis, which is conducted by a blinded data analyst.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Gold-coated fixed retainer wire

Participants will receive a mandibular canine-to-canine fixed retainer fabricated and bonded using the standardized protocol. The allocated device is a 0.0195-inch gold-plated multistranded wire (penta twist, five-strand).

Group Type EXPERIMENTAL

Gold-coated fixed retainer wire

Intervention Type DEVICE

Participants will receive a bonded mandibular fixed retainer extending canine-to-canine. The retainer will be fabricated using a gold-coated retainer wire and bonded to the lingual surfaces of the mandibular anterior teeth using standard orthodontic bonding procedures. After placement, participants will be followed at scheduled visits (baseline and follow-ups at 1 month, 3 months, and 6 months) to evaluate clinical stability and retainer performance. At each follow-up visit, the retainer will be clinically examined for integrity, and any failure/complication events will be recorded (e.g., debonding/loosening, fracture, or need for repair). Clinical outcome assessments will include mandibular anterior alignment/stability (Little's Irregularity Index), periodontal indices, and occlusal assessment, Microbiological sampling will consist of plaque/swab samples collected at each follow-up visit.

Stainless steel fixed retainer wire

Participants will receive a mandibular canine-to-canine fixed retainer fabricated and bonded using the standardized protocol. The allocated device is a 0.0195-inch dead-soft multistranded stainless-steel wire (coaxial, six-strand).

Group Type ACTIVE_COMPARATOR

Stainless steel fixed retainer wire

Intervention Type DEVICE

Participants will receive a bonded mandibular fixed retainer extending canine-to-canine. The retainer will be fabricated using a conventional stainless steel retainer wire and bonded to the lingual surfaces of the mandibular anterior teeth using standard orthodontic bonding procedures. After placement, participants will be followed at scheduled visits (baseline and follow-ups at, 1 month, 3 months, and 6 months) to evaluate clinical stability and retainer performance. At each follow-up visit, the retainer will be clinically examined for integrity, and any failure/complication events will be recorded (e.g., debonding/loosening, fracture, or need for repair). Clinical outcome assessments will include mandibular anterior alignment/stability (Little's Irregularity Index), periodontal indices, and occlusal assessment. Microbiological sampling will consist of plaque/swab samples collected at each follow-up visit.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gold-coated fixed retainer wire

Participants will receive a bonded mandibular fixed retainer extending canine-to-canine. The retainer will be fabricated using a gold-coated retainer wire and bonded to the lingual surfaces of the mandibular anterior teeth using standard orthodontic bonding procedures. After placement, participants will be followed at scheduled visits (baseline and follow-ups at 1 month, 3 months, and 6 months) to evaluate clinical stability and retainer performance. At each follow-up visit, the retainer will be clinically examined for integrity, and any failure/complication events will be recorded (e.g., debonding/loosening, fracture, or need for repair). Clinical outcome assessments will include mandibular anterior alignment/stability (Little's Irregularity Index), periodontal indices, and occlusal assessment, Microbiological sampling will consist of plaque/swab samples collected at each follow-up visit.

Intervention Type DEVICE

Stainless steel fixed retainer wire

Participants will receive a bonded mandibular fixed retainer extending canine-to-canine. The retainer will be fabricated using a conventional stainless steel retainer wire and bonded to the lingual surfaces of the mandibular anterior teeth using standard orthodontic bonding procedures. After placement, participants will be followed at scheduled visits (baseline and follow-ups at, 1 month, 3 months, and 6 months) to evaluate clinical stability and retainer performance. At each follow-up visit, the retainer will be clinically examined for integrity, and any failure/complication events will be recorded (e.g., debonding/loosening, fracture, or need for repair). Clinical outcome assessments will include mandibular anterior alignment/stability (Little's Irregularity Index), periodontal indices, and occlusal assessment. Microbiological sampling will consist of plaque/swab samples collected at each follow-up visit.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: 15-30 years.
* Patients who have completed comprehensive orthodontic treatment ,with well-aligned mandibular anterior teeth (Little's Irregularity Index ≤ 0.5 mm) at debond; both extraction and non-extraction cases are eligible.
* Patients with good oral hygiene and healthy periodontium at baseline; no previous bonded retainer.
* All mandibular anterior teeth present (canine-canine), with sound lingual enamel suitable for bonding.

Exclusion Criteria

* Patients with a history of rapid maxillary expansion (RME) or surgically assisted RME (SARME).
* Patients with a cleft lip / and or palate (craniofacial anomalies).
* Patients with marked deep overbite and/or parafunctional habits (e.g., bruxism, clenching).
* Patients with conditions precluding reliable bonding in the mandibular anterior segment (active caries, extensive restorations, enamel fractures) or missing teeth from canine to canine.
* Patients with medical/periodontal conditions likely to affect gingival health (e.g., active periodontitis, uncontrolled systemic disease).
Minimum Eligible Age

15 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Noor Sattar Raheem

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Noor Sattar Raheem

Postgraduate Researcher (Principal Investigator)

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

NOOR NOOR, BDS

Role: PRINCIPAL_INVESTIGATOR

noor sattar

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

College of Dentistry, University of Baghdad - Orthodontic Clinics

Baghdad, Baghdad Governorate, Iraq

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Iraq

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

NOOR Raheem, BDS

Role: CONTACT

+9647704514927

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

NOOR Raheem, BDS

Role: primary

+9647704514927

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UOB-RCT-ORTHO-GOLDSS-2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.